Rankings
▼
Calendar
NERV
Minerva Neurosciences, Inc.
$52M
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-1.44
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$832,775
Balance Sheet
Total Assets
$147M
Total Liabilities
$26M
Stockholders' Equity
$121M
Cash & Equivalents
$89M
← FY 2016
All Quarters
Q3 2016 →
NERV Q2 2016 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena
